Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

These findings suggest that IGFBP-2 and, to a lesser extent, FGF-21 may serve as early biomarkers of cognitive impairment, reflecting intricate links between peripheral dysmetabolism and AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2026-02-01
DOI
https://doi.org/10.1002/alz.71097
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

Andréanne Loiselle, Caroline Dallaire‐Théroux, Marine Tournissac, Anne Gangloff et al.
Alzheimer s & Dementia
Fibroblast Growth Factor Research
article

Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

Andréanne Loiselle, Caroline Dallaire‐Théroux, Marine Tournissac, Anne Gangloff, Frédéric Picard, Hélèna L. Denis, Olivier Potvin, Manon Leclerc, Amélie Provencher, Rosalie Juliette Cottez, Frederic Calon, Cyntia Tremblay, S. Belleville, Henrik Zetterberg, Josue Valentin‐Escalera
article en

Abstract

These findings suggest that IGFBP-2 and, to a lesser extent, FGF-21 may serve as early biomarkers of cognitive impairment, reflecting intricate links between peripheral dysmetabolism and AD.

Alzheimer s & DementiaVol. 22(2)
University of Wisconsin–Madison (US), Sahlgrenska University Hospital (SE), Lung Institute (US), Institut Universitaire de Gériatrie de Montréal (CA), Hôpital de l'Enfant-Jésus (CA), Centre hospitalier de l'Université Laval (CA), National Hospital for Neurology and Neurosurgery (GB), Université Laval (CA), University College London (GB), University of Gothenburg (SE)
Pfizer, Réseau québécois de recherche sur le vieillissement, Ministère de la Santé et des Services sociaux, Consortium canadien en neurodégénérescence associée au vieillissement, European Commission, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Courtois Foundation, HORIZON EUROPE Framework Programme, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé
Openalex Percentile: Top 69%
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.